Trade Policy & Tariffs
High ImpactNov 4, 2026BIS Defines Pharma Products Exempt from Section 232 Tariffs
The Bureau of Industry and Security has issued critical guidance defining which pharmaceutical products qualify for zero-tariff treatment under Section 232, addressing Presidential Proclamation 11020
Sandler, Travis & Rosenberg, P.A.#section-232-tariffs#pharmaceutical-tariffs#trade-policy
